Eli Lilly Chairman & CEO David Ricks discusses GLP-1's, Alzheimer's, business development and more

<p>From the company&#39;s headquarters in Indianapolis, he describes where he thinks the obesity field could be headed in the next few years, what might be next after beta-amyloid in Alzheimer&#39;s, and how he plans to invest for the future.</p>